2021
DOI: 10.1016/j.cmi.2020.12.005
|View full text |Cite
|
Sign up to set email alerts
|

Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

9
161
3
5

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 129 publications
(178 citation statements)
references
References 20 publications
9
161
3
5
Order By: Relevance
“…33,34 So far, only few studies have investigated fungal superinfections in COVID-19 patients. [13][14][15]17,[35][36][37] The significance of viral reactivation remains unclear. 11 In our study, reactivations of HSV-1 and HHV-6 in the serum occurred in patients with bacterial superinfections.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…33,34 So far, only few studies have investigated fungal superinfections in COVID-19 patients. [13][14][15]17,[35][36][37] The significance of viral reactivation remains unclear. 11 In our study, reactivations of HSV-1 and HHV-6 in the serum occurred in patients with bacterial superinfections.…”
Section: Discussionmentioning
confidence: 99%
“…11,12 However, COVID-19-associated pulmonary aspergillosis (CAPA) has been reported in several cohorts of critically ill patients. 13,14 Still, there is a lack of knowledge about the frequency and significance of bacterial, fungal, and viral concomitant infections in critically ill COVID-19 patients. 12 Additionally, in most studies performed so far, no thorough and systematic sampling for concomitant infections was performed.…”
Section: Introductionmentioning
confidence: 99%
“…Because SARS-CoV-2 and treatments such as dexamethasone or tocilizumab can impair the immune system, some researchers anticipated the possibility of fungal superinfection among COVID-19 patients ( 3 – 6 ). As of August 2020, researchers have documented COVID-19–associated pulmonary aspergillosis (CAPA) ( 7 9 ), invasive candidiasis ( 10 ), coccidioidomycosis ( 11 ), fusariosis ( 12 ), histoplasmosis ( 13 ), mucormycosis ( 14 ), pneumocystosis ( 15 ), and saccharomycosis ( 16 ). Varying cumulative rates of CAPA have been described, including rates of 0.7%–7.7% among COVID-19 patients ( 17 , 18 ), 2.5%–39.1% among ICU patients with COVID-19 ( 19 , 20 ), and 3.2%–29.6% among COVID-19 patients on mechanical ventilation ( 7 , 17 ).…”
mentioning
confidence: 99%
“…Much of the latter includes opportunistic Gram-negative bacilli [49,100,118,119,123,124,126,137,138,140,144,145,147,148]. Fungal infections, especially with Candida spp., occur with worse disease and increased hospital stay [118,126,135,136,139,144,145,147,[149][150][151]. The latter may occur in up to 14% of such patients [134,138,139].…”
Section: The Impact Of Covid-19 On Associated Post-onset Bacterial Infectionsmentioning
confidence: 99%
“…The latter may occur in up to 14% of such patients [134,138,139]. As anticipated, antimicrobial therapy and steroid use can pose as risk factors for such invasive fungal infections [147,151].…”
Section: The Impact Of Covid-19 On Associated Post-onset Bacterial Infectionsmentioning
confidence: 99%